Eintrag weiter verarbeiten
A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
Gespeichert in:
Zeitschriftentitel: | CA: A Cancer Journal for Clinicians |
---|---|
Personen und Körperschaften: | , , , , |
In: | CA: A Cancer Journal for Clinicians, 69, 2019, 1, S. 50-79 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Wiley
|
Schlagwörter: |
author_facet |
Wender, Richard C. Brawley, Otis W. Fedewa, Stacey A. Gansler, Ted Smith, Robert A. Wender, Richard C. Brawley, Otis W. Fedewa, Stacey A. Gansler, Ted Smith, Robert A. |
---|---|
author |
Wender, Richard C. Brawley, Otis W. Fedewa, Stacey A. Gansler, Ted Smith, Robert A. |
spellingShingle |
Wender, Richard C. Brawley, Otis W. Fedewa, Stacey A. Gansler, Ted Smith, Robert A. CA: A Cancer Journal for Clinicians A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control Oncology Hematology |
author_sort |
wender, richard c. |
spelling |
Wender, Richard C. Brawley, Otis W. Fedewa, Stacey A. Gansler, Ted Smith, Robert A. 0007-9235 1542-4863 Wiley Oncology Hematology http://dx.doi.org/10.3322/caac.21550 <jats:title>Abstract</jats:title><jats:p>From the mid‐20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and invasive disease at a more favorable stage has contributed substantially to reduced incidence, morbidity, and mortality. However, as new discoveries portend advancements in technology and risk‐based screening, we fail to fulfill the greatest potential of the existing technology, in terms of both full access among the target population and the delivery of state‐of‐the art care at each crucial step in the cascade of events that characterize successful cancer screening. There also is insufficient commitment to invest in the development of new technologies, incentivize the development of new ideas, and rapidly evaluate promising new technology. In this report, the authors summarize the status of cancer screening and propose a blueprint for the nation to further advance the contribution of screening to cancer control.</jats:p> A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control CA: A Cancer Journal for Clinicians |
doi_str_mv |
10.3322/caac.21550 |
facet_avail |
Online Free |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyMi9jYWFjLjIxNTUw |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyMi9jYWFjLjIxNTUw |
institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Zi4 DE-Gla1 DE-15 DE-Pl11 DE-Rs1 DE-14 DE-105 DE-Ch1 DE-L229 |
imprint |
Wiley, 2019 |
imprint_str_mv |
Wiley, 2019 |
issn |
0007-9235 1542-4863 |
issn_str_mv |
0007-9235 1542-4863 |
language |
English |
mega_collection |
Wiley (CrossRef) |
match_str |
wender2019ablueprintforcancerscreeningandearlydetectionadvancingscreeningscontributiontocancercontrol |
publishDateSort |
2019 |
publisher |
Wiley |
recordtype |
ai |
record_format |
ai |
series |
CA: A Cancer Journal for Clinicians |
source_id |
49 |
title |
A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control |
title_unstemmed |
A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control |
title_full |
A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control |
title_fullStr |
A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control |
title_full_unstemmed |
A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control |
title_short |
A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control |
title_sort |
a blueprint for cancer screening and early detection: advancing screening’s contribution to cancer control |
topic |
Oncology Hematology |
url |
http://dx.doi.org/10.3322/caac.21550 |
publishDate |
2019 |
physical |
50-79 |
description |
<jats:title>Abstract</jats:title><jats:p>From the mid‐20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and invasive disease at a more favorable stage has contributed substantially to reduced incidence, morbidity, and mortality. However, as new discoveries portend advancements in technology and risk‐based screening, we fail to fulfill the greatest potential of the existing technology, in terms of both full access among the target population and the delivery of state‐of‐the art care at each crucial step in the cascade of events that characterize successful cancer screening. There also is insufficient commitment to invest in the development of new technologies, incentivize the development of new ideas, and rapidly evaluate promising new technology. In this report, the authors summarize the status of cancer screening and propose a blueprint for the nation to further advance the contribution of screening to cancer control.</jats:p> |
container_issue |
1 |
container_start_page |
50 |
container_title |
CA: A Cancer Journal for Clinicians |
container_volume |
69 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792346186369204233 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T17:35:23.047Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+blueprint+for+cancer+screening+and+early+detection%3A+Advancing+screening%E2%80%99s+contribution+to+cancer+control&rft.date=2019-01-01&genre=article&issn=1542-4863&volume=69&issue=1&spage=50&epage=79&pages=50-79&jtitle=CA%3A+A+Cancer+Journal+for+Clinicians&atitle=A+blueprint+for+cancer+screening+and+early+detection%3A+Advancing+screening%E2%80%99s+contribution+to+cancer+control&aulast=Smith&aufirst=Robert+A.&rft_id=info%3Adoi%2F10.3322%2Fcaac.21550&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792346186369204233 |
author | Wender, Richard C., Brawley, Otis W., Fedewa, Stacey A., Gansler, Ted, Smith, Robert A. |
author_facet | Wender, Richard C., Brawley, Otis W., Fedewa, Stacey A., Gansler, Ted, Smith, Robert A., Wender, Richard C., Brawley, Otis W., Fedewa, Stacey A., Gansler, Ted, Smith, Robert A. |
author_sort | wender, richard c. |
container_issue | 1 |
container_start_page | 50 |
container_title | CA: A Cancer Journal for Clinicians |
container_volume | 69 |
description | <jats:title>Abstract</jats:title><jats:p>From the mid‐20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and invasive disease at a more favorable stage has contributed substantially to reduced incidence, morbidity, and mortality. However, as new discoveries portend advancements in technology and risk‐based screening, we fail to fulfill the greatest potential of the existing technology, in terms of both full access among the target population and the delivery of state‐of‐the art care at each crucial step in the cascade of events that characterize successful cancer screening. There also is insufficient commitment to invest in the development of new technologies, incentivize the development of new ideas, and rapidly evaluate promising new technology. In this report, the authors summarize the status of cancer screening and propose a blueprint for the nation to further advance the contribution of screening to cancer control.</jats:p> |
doi_str_mv | 10.3322/caac.21550 |
facet_avail | Online, Free |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyMi9jYWFjLjIxNTUw |
imprint | Wiley, 2019 |
imprint_str_mv | Wiley, 2019 |
institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229 |
issn | 0007-9235, 1542-4863 |
issn_str_mv | 0007-9235, 1542-4863 |
language | English |
last_indexed | 2024-03-01T17:35:23.047Z |
match_str | wender2019ablueprintforcancerscreeningandearlydetectionadvancingscreeningscontributiontocancercontrol |
mega_collection | Wiley (CrossRef) |
physical | 50-79 |
publishDate | 2019 |
publishDateSort | 2019 |
publisher | Wiley |
record_format | ai |
recordtype | ai |
series | CA: A Cancer Journal for Clinicians |
source_id | 49 |
spelling | Wender, Richard C. Brawley, Otis W. Fedewa, Stacey A. Gansler, Ted Smith, Robert A. 0007-9235 1542-4863 Wiley Oncology Hematology http://dx.doi.org/10.3322/caac.21550 <jats:title>Abstract</jats:title><jats:p>From the mid‐20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and invasive disease at a more favorable stage has contributed substantially to reduced incidence, morbidity, and mortality. However, as new discoveries portend advancements in technology and risk‐based screening, we fail to fulfill the greatest potential of the existing technology, in terms of both full access among the target population and the delivery of state‐of‐the art care at each crucial step in the cascade of events that characterize successful cancer screening. There also is insufficient commitment to invest in the development of new technologies, incentivize the development of new ideas, and rapidly evaluate promising new technology. In this report, the authors summarize the status of cancer screening and propose a blueprint for the nation to further advance the contribution of screening to cancer control.</jats:p> A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control CA: A Cancer Journal for Clinicians |
spellingShingle | Wender, Richard C., Brawley, Otis W., Fedewa, Stacey A., Gansler, Ted, Smith, Robert A., CA: A Cancer Journal for Clinicians, A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control, Oncology, Hematology |
title | A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control |
title_full | A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control |
title_fullStr | A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control |
title_full_unstemmed | A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control |
title_short | A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control |
title_sort | a blueprint for cancer screening and early detection: advancing screening’s contribution to cancer control |
title_unstemmed | A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control |
topic | Oncology, Hematology |
url | http://dx.doi.org/10.3322/caac.21550 |